As the executive vice president, chief medical officer and head of development at Bristol Myers Squibb, Samit Hirawat ...

(Image/Freepik) When Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, was looking to expand its ...

David Risinger, an analyst from Leerink Partners, maintained the Hold rating on Bristol-Myers Squibb (BMY – Research Report). The associated price target was raised to $55.00. David Risinger has given ...